EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pathogenic spectrum and drug resistance of bloodstream infection in patients with acute myeloid leukaemia: a single centre retrospective study

Han Wu, Manning Li, Chunyi Shou, Fangfang Shi, Xiaolu Song, Qingfeng Hu, Ying Wang, Yirui Chen, Xiangmin Tong

Frontiers in Cellular and Infection Microbiology · 07.06.2024 · 14

DOI: 10.3389/fcimb.2024.1390053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 07.06.2024. Verfasst von Han Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Clinical Medicine, Jinzhou Medical University, Jinzhou, Liaoning, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Bacteremia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bloodstream infection (BSI) represent a prevalent complication in haematological malignancies (HMs). Typically, Patients with BSI usually undergo empirical treatment pending pathogen identification. The timely and effective management of BSIs significantly influences patient prognosis. However, pathogen distribution in BSIs exhibits regional variation. In this study, we investigated the clinical characteristics, pathogen spectrum, drug resistance, risk factors of short-term prognosis and long-term prognostic factors of acute myeloid leukemia (AML) patients with BSI at Zhejiang Provincal People’s Hospital.

Methods

From 2019 to 2021, a total of 56 AML patients with BSI were treated in the Department of Haematology at Zhejiang Province People’s Hospital. Data regarding pathogen spectrum and drug resistance were collected for analysis. The patients were stratified into non-survivor cohort and survivor cohort within 30 days after BSI, and the predictors of 30-days mortality were identified through both univariate and multivariate Logistic regression analyses. Furthermore, Kaplan-Meier survival analysis and Cox regression analysis were employed to ascertain the risk factors associated with poor prognosis in AML patients complicated by BSI.

Results

A total of 70 strains of pathogenic bacteria were isolated from 56 AML patients with BSI. Gram-negative bacteria constituted the predominant pathogens (71.4%), with Klebsiella pneumoniae being the most prevalent (22.9%). Gram-positive bacteria and fungi accounted for 22.9% and 5.7%, respectively. Univariate and multivariate analyses revealed significant differences in total protein, albumin levels, and the presence of septic shock between the non-survivor cohort and the survior cohort 30 days post-BSI. COX regression analysis showed that agranulocytosis duration exceeding 20 days (HR:3.854; 95% CI: 1.451–10.242) and septic shock (HR:3.788; 95% CI: 1.729–8.299) were independent risk factors for poor prognosis in AML patients complicated by BSI. Notably, the mortality rate within 30 days after Stenotrophomonas maltophilia infection was up to 71.4%.

Conclusions

In this study, Gram-negative bacteria, predominantly Klebsiella pneumoniae, constituted the primary pathogens among AML patients with BSIs. Serum albumin levels and the presence of septic shock emerged as independent risk factors for mortality within 30 days among AML patients with BSI. In terms of long-term prognosis, extended agranulocytosis duration exceeding 20 days and septic shock were associated with elevated mortality rates in AML patients with BSI. Additionally, in our centre, Stenotrophomonas maltophilia infection was found to be associated with a poor prognosis. Early intervention for Stenotrophomonas maltophilia infection in our centre could potentially improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteBacteremiaHumansMaleFemaleMiddle AgedRetrospective StudiesAdultRisk FactorsAgedPrognosisAnti-Bacterial AgentsChinaDrug Resistance, BacterialYoung AdultBacteriaGram-Negative Bacteria

Stichwörter der Autor:innen

acute myeloid leukaemiabloodstream infectionsdistribution of pathogenic bacteriadrug resistanceprognosisrisk factors

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Graduate School of Clinical Medicine, Jinzhou Medical University, Jinzhou, Liaoning, China.
  • Cancer Center, Department of Hematology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Department of Central Laboratory, Affiliated Hangzhou First People's Hospital, Xihu University, Hangzhou, Zhejiang, China.
  • Department of Hematology, Affiliated Hangzhou First People's Hospital, Xihu University, Hangzhou, Zhejiang, China.

Zitieren

APA

Wu, H., Li, M., Shou, C., Shi, F., Song, X., Hu, Q., Wang, Y., Chen, Y., & Tong, X. (2024). Pathogenic spectrum and drug resistance of bloodstream infection in patients with acute myeloid leukaemia: a single centre retrospective study. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1390053

Vancouver

Wu H, Li M, Shou C, Shi F, Song X, Hu Q, et al. Pathogenic spectrum and drug resistance of bloodstream infection in patients with acute myeloid leukaemia: a single centre retrospective study. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1390053

BibTeX
@article{Wu2024,
  author = {Wu, Han and Li, Manning and Shou, Chunyi and Shi, Fangfang and Song, Xiaolu and Hu, Qingfeng and Wang, Ying and Chen, Yirui and Tong, Xiangmin},
  title = {Pathogenic spectrum and drug resistance of bloodstream infection in patients with acute myeloid leukaemia: a single centre retrospective study},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fcimb.2024.1390053}
}
Kostenlos starten →